True North Therapeutics

Acquired

True North Therapeutics is a biotech company in South San Francisco, United States, founded in 2013. It has raised $142.0M across 4 rounds, most recently a $45.0M Series D in October 2016.

Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA

Employees
11–50
Founded
2013
Business Model
B2B
Website
sanofi.us
Total Funding
$142.0M
Last Round
$45.0M Series DOct 2016
Rounds
4
Acquisition Date
May 2017

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.

About

True North Therapeutics is a biotechnology company that selectively inhibits the Complement pathway for diseases of high unmet clinical need. Its lead monoclonal antibody, TNT009, targets the Classical Complement pathway so downstream phagocytosis, inflammation, and cell lysis can be blocked. The company focuses on Complement-mediated rare diseases in the hematologic, renal, and neurological space. True North was formed in 2013 as a spin-out of iPierian.

Summary

It lists 11–50 employees. It has raised $142.0M in total across 4 rounds, most recently a $45.0M Series D round in Oct 2016. Investors include OrbiMed, Baxter Ventures and MPM Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionMay 2017

Sign up to see all 5 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

True North Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/true-north-therapeutics"><img src="https://indexed.vc/api/badge/company/true-north-therapeutics" alt="True North Therapeutics on Indexed.vc" width="260" height="76" /></a>